scholarly journals Contribution of Blood Phosphate Esters to the Blood Saccharoid Fraction of Rats with Alloxan-induced Diabetes or Treated with Insulin or Epinephrine

1974 ◽  
Vol 20 (9) ◽  
pp. 1165-1172 ◽  
Author(s):  
Zeenat- un-Nisa ◽  
M Ataur Rahman
Keyword(s):  
Ascorbic Acid ◽  
Uric Acid ◽  
Whole Blood ◽  
Glucuronic Acid ◽  
Weak Acid ◽  
Diabetic Rats ◽  
Phosphate Esters ◽  
Experimental Conditions ◽  
Dynamic Character ◽  
Reducing Substances

Abstract Nonglucose reducing substances in blood constitute the "saccharoid fraction," which increases both in hyperand hypoglycemia. The phosphate esters, including weak-acid phosphates and fructose-1,6-diphosphate, constitute 14 to 25% of the saccharoid fraction in whole blood, 2 to 9% in plasma, and 24 to 35% in erythrocytes of normal rats treated with insulin or epinephrine and of alloxan diabetic rats treated with insulin. Glutathione, glucuronic acid, ascorbic acid, uric acid, and creatinine (reported earlier) and the phosphate esters (reported here) altogether account for 75 to 100% of the saccharoid fraction under the experimental conditions used, except in the alloxan-diabetic rats, where on the fourth day of alloxan treatment a larger proportion was unaccounted for. The dynamic character of the saccharoid fraction is probably due to the evanescent nature of these phosphate esters.

Changes in the Saccharoid Fraction in Rats with Alloxan-Induced Diabetes or Injected with Epinephrine

1971 ◽  
Vol 17 (9) ◽  
pp. 915-920 ◽  
Author(s):  
M Jafar Alam ◽  
M Ataur Rahman
Keyword(s):  
Ascorbic Acid ◽  
Uric Acid ◽  
Blood Glucose ◽  
Glucose Concentration ◽  
Glucuronic Acid ◽  
Blood Glucose Concentration ◽  
Diabetic Rats ◽  
Reducing Sugar ◽  
Sugar Phosphates ◽  
Reducing Substances

Abstract "Saccharoid fraction," defined as the nonglucose reducing substances in blood, increases both in hyperglycemia (blood glucose concentration exceeding 280 mg/dl) and hypoglycemia (blood sugar less than 65 mg/dl) in rats. This increase is not completely accounted for by glutathione, glucuronic acid, ascorbic acid, uric acid, and creatinine. Some of the constituents of saccharoid fraction seem to be insulin-sensitive. Alloxan not only produces diabetes in rats but also increases blood glucuronic acid, ascorbic acid, and uric acid. Estimated constituents of saccharoid fraction account for only 45% to 75% of the saccharoid fraction. The unaccounted-for saccharoid fraction shows changes similar to those in the accounted-for saccharoid fraction, in the diabetic rats, as was also the case after treatment with insulin of normal or diabetic animals. The fraction not accounted for by the estimated constituents may represent the reducing sugar phosphates present in the blood.

scholarly journals Regulation of ascorbic acid and of xylulose synthesis in rat-liver extracts. The effect of alloxan-diabetes on the glucuronic acid pathway

1965 ◽  
Vol 97 (2) ◽  
pp. 561-564 ◽  
Author(s):  
F Stirpe ◽  
M Comporti
Keyword(s):  
Ascorbic Acid ◽  
Insulin Therapy ◽  
Rat Liver ◽  
Alloxan Diabetes ◽  
Glucuronic Acid ◽  
Diabetic Rats ◽  
Acid Pathway

1. The synthesis of l-ascorbic acid and of l-xylulose from d-glucuronolactone, d-glucuronate, l-gulonate and l-gulonolactone has been studied with liver extracts from normal and alloxan-diabetic rats. 2. In diabetic animals the synthesis of ascorbic acid is impaired, and more from glucuronolactone and glucuronate than from gulonate and gulonolactone, whereas the formation of xylulose from gulonate and gulonolactone is enhanced. These changes are reversed by insulin therapy. 3. The activity of the NAD-linked gulonate dehydrogenase is enhanced during diabetes.

Modified Glucose Oxidase Method for Determination of Glucose in Whole Blood

1973 ◽  
Vol 19 (3) ◽  
pp. 308-311 ◽  
Author(s):  
Samuel Meites ◽  
Karen Saniel-Banrey
Keyword(s):  
Ascorbic Acid ◽  
Uric Acid ◽  
Glucose Oxidase ◽  
Whole Blood ◽  
Enzyme Concentration ◽  
Capillary Blood ◽  
Protein Precipitation ◽  
Analytical Time

Abstract We have modified an ultramicro method for determining glucose with glucose oxidase—peroxidase—odianisidine. Capillary blood is diluted in isotonic NaF (17.6-17.8 g/ liter), the cells are removed, and glucose is determined after a 20-min incubation with enzyme-containing reagent. Increasing the enzyme concentration fourfold nullifies interference from ascorbic acid and hemolysis, while greatly decreasing interference from bilirubinemia. If necessary, bilirubin is removed completely by coprecipitation with protein. Interference from uric acid is minimized by incorporating it into the standards. Several other suspected interferences proved inconsequential. Isotonic NaF does not inhibit the enzymes used, and preserves glucose in blood for at least 2 h. Avoiding protein precipitation and shortening the incubating time significantly lessens analytical time without affecting precision.

Stability of antioxidant vitamins in whole human blood during overnight storage at 4°C and frozen storage up to 6 months

2018 ◽  
Vol 88 (3-4) ◽  
pp. 151-157 ◽  
Author(s):  
Scott W. Leonard ◽  
Gerd Bobe ◽  
Maret G. Traber
Keyword(s):  
Ascorbic Acid ◽  
Whole Blood ◽  
Healthy Subjects ◽  
Frozen Storage ◽  
Blood Collection ◽  
Plasma Samples ◽  
Optimal Conditions ◽  
Plasma Ascorbic Acid ◽  
Blood Samples ◽  
Sample Handling

Abstract. To determine optimal conditions for blood collection during clinical trials, where sample handling logistics might preclude prompt separation of erythrocytes from plasma, healthy subjects (n=8, 6 M/2F) were recruited and non-fasting blood samples were collected into tubes containing different anticoagulants (ethylenediaminetetra-acetic acid (EDTA), Li-heparin or Na-heparin). We hypothesized that heparin, but not EDTA, would effectively protect plasma tocopherols, ascorbic acid, and vitamin E catabolites (α- and γ-CEHC) from oxidative damage. To test this hypothesis, one set of tubes was processed immediately and plasma samples were stored at −80°C, while the other set was stored at 4°C and processed the following morning (~30 hours) and analyzed, or the samples were analyzed after 6 months of storage. Plasma ascorbic acid, as measured using HPLC with electrochemical detection (LC-ECD) decreased by 75% with overnight storage using EDTA as an anticoagulant, but was unchanged when heparin was used. Neither time prior to processing, nor anticoagulant, had any significant effects upon plasma α- or γ-tocopherols or α- or γ-CEHC concentrations. α- and γ-tocopherol concentrations remained unchanged after 6 months of storage at −80°C, when measured using either LC-ECD or LC/mass spectrometry. Thus, refrigeration of whole blood at 4°C overnight does not change plasma α- or γ-tocopherol concentrations or their catabolites. Ascorbic acid is unstable in whole blood when EDTA is used as an anticoagulant, but when whole blood is collected with heparin, it can be stored overnight and subsequently processed.

Molecularly Imprinted Sensor for Ascorbic Acid Based on Gold Nanoparticles and Multiwalled Carbon Nanotubes

2020 ◽  
Vol 16 (7) ◽  
pp. 905-913
Author(s):  
Youyuan Peng ◽  
Qingshan Miao
Keyword(s):  
Carbon Nanotubes ◽  
Gold Nanoparticles ◽  
Ascorbic Acid ◽  
Multiwalled Carbon Nanotubes ◽  
Ph Value ◽  
Biological Fluids ◽  
Water Soluble ◽  
Multiwalled Carbon ◽  
Experimental Conditions ◽  
Molecularly Imprinted

Background: L-Ascorbic acid (AA) is a kind of water soluble vitamin, which is mainly present in fruits, vegetables and biological fluids. As a low cost antioxidant and effective scavenger of free radicals, AA may help to prevent diseases such as cancer and Parkinson’s disease. Owing to its role in the biological metabolism, AA has also been utilized for the therapy of mental illness, common cold and for improving the immunity. Therefore, it is very necessary and urgent to develop a simple, rapid and selective strategy for the detection of AA in various samples. Methods: The molecularly imprinted poly(o-phenylenediamine) (PoPD) film was prepared for the analysis of L-ascorbic acid (AA) on gold nanoparticles (AuNPs) - multiwalled carbon nanotubes (MWCNTs) modified glass carbon electrode (GCE) by electropolymerization of o-phenylenediamine (oPD) and AA. Experimental parameters including pH value of running buffer and scan rates were optimized. Scanning electron microscope (SEM), fourier-transform infrared (FTIR) spectra, cyclic voltammetry (CV) and differential pulse voltammetry (DPV) were utilized for the characterization of the imprinted polymer film. Results: Under the selected experimental conditions, the DPV peak currents of AA exhibit two distinct linear responses ranging from 0.01 to 2 μmol L-1 and 2 to 100 μmol L-1 towards the concentrations of AA, and the detection limit was 2 nmol L-1 (S/N=3). Conclusion: The proposed electrochemical sensor possesses excellent selectivity for AA, along with good reproducibility and stability. The results obtained from the analysis of AA in real samples demonstrated the applicability of the proposed sensor to practical analysis.

scholarly journals Cigarette smoke inhalation aggravates diabetic kidney injury in rats

2019 ◽  
Vol 8 (6) ◽  
pp. 964-971 ◽  
Author(s):  
Songling Jiang ◽  
Do Van Quan ◽  
Jae Hyuck Sung ◽  
Moo-Yeol Lee ◽  
Hunjoo Ha
Keyword(s):  
Kidney Disease ◽  
Cigarette Smoke ◽  
Density Lipoprotein ◽  
Kidney Injury ◽  
Diabetic Rats ◽  
Smoke Inhalation ◽  
Lipoprotein Cholesterol ◽  
Sprague Dawley ◽  
Experimental Conditions ◽  
Diabetic Kidney

Abstract Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease. Epidemiological studies have demonstrated that cigarette smoke or nicotine is a risk factor for the progression of chronic kidney injury. The present study analyzed the kidney toxicity of cigarette smoke in experimental rats with DKD. Experimental diabetes was induced in 7-week-old Sprague-Dawley rats by a single intraperitoneal injection of streptozotocin (60 mg kg−1). Four weeks after the induction of diabetes, rats were exposed to cigarette smoke (200 μg L−1), 4 h daily, and 5 days per week for 4 weeks. Cigarette smoke did not affect the levels of plasma glucose, hemoglobin A1c, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol or non-esterified fatty acids in both control and diabetic rats under the experimental conditions. Cigarette smoke, however, significantly increased diabetes-induced glomerular hypertrophy and urinary kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) excretion, suggesting exacerbation of diabetic kidney injury. Cigarette smoke promoted macrophage infiltration and fibrosis in the diabetic kidney. As expected, cigarette smoke increased oxidative stress in both control and diabetic rats. These data demonstrated that four weeks of exposure to cigarette smoke aggravated the progression of DKD in rats.

scholarly journals Interference of ascorbic acid with chemical analytes

2005 ◽  
Vol 42 (6) ◽  
pp. 475-477 ◽  
Author(s):  
Qing H Meng ◽  
William C Irwin ◽  
Jennifer Fesser ◽  
K Lorne Massey
Keyword(s):  
Ascorbic Acid ◽  
Creatine Kinase ◽  
Uric Acid ◽  
Total Cholesterol ◽  
Acid Concentration ◽  
Total Bilirubin ◽  
Binding Capacity ◽  
Ascorbic Acid Concentration ◽  
Sodium Potassium ◽  
Creatine Kinase Mb

Background: Ascorbic acid can interfere with methodologies involving redox reactions, while comprehensive studies on main chemistry analysers have not been reported. We therefore attempted to determine the interference of ascorbic acid with analytes on the Beckman Synchron LX20®. Methods: Various concentrations of ascorbic acid were added to serum, and the serum analytes were measured on the LX20. Results: With a serum ascorbic acid concentration of 12.0 mmol/L, the values for sodium, potassium, calcium and creatinine increased by 43%, 58%, 103% and 26%, respectively ( P<0.01). With a serum ascorbic acid concentration of 12.0 mmol/L, the values for chloride, total bilirubin and uric acid decreased by 33%, 62% and 83%, respectively ( P<0.01), and were undetectable for total cholesterol, triglyceride, ammonia and lactate. There was no definite influence of ascorbic acid on analytical values for total CO2, urea, glucose, phosphate, total protein, albumin, amylase, creatine kinase, creatine kinase-MB, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total iron, unbound iron-binding capacity or magnesium. Conclusions: Ascorbic acid causes a false increase in sodium, potassium, calcium and creatinine results and a false decrease in chloride, total bilirubin, uric acid, total cholesterol, triglyceride, ammonia and lactate results.

Sign in / Sign up

Export Citation Format

Share Document